← SynDRA
OXYBUTYNIN
SynDRA canonical compound SYN0004756 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | CHRM3 |
| Mechanism of action | Acetylcholine receptor antagonist |
| Indication | urinary incontinence |
| Disease area | urology |
All known targets
- CHRM3
- CHRM2
- CHRM1
- CHRM4
- CHRM5
- CYP2C19
- Chrm1
- Chrm2
- Chrm3
- DRD3
- HTR2B
- Pgrmc1
Mechanisms of action (all sources)
- Acetylcholine receptor antagonist
- CHRM3 ANTAGONIST
- Muscarinic acetylcholine receptor M3 antagonist
- CHRM2 ANTAGONIST
- Muscarinic acetylcholine receptor M2 antagonist
- CHRM1 ANTAGONIST
- CHRM2 INVERSE AGONIST
- CHRM4 ANTAGONIST
- CHRM5 ANTAGONIST
Drug classes
- Cholinergic Muscarinic Antagonists
- Cholinergic Agents
- Cholinergic Antagonists
- Muscarinic Antagonists
- Neurotransmitter Agents
- Parasympatholytics
- Peripheral Nervous System Agents
- Urological Agents
- Cholinergic Muscarinic Antagonist
ATC classes
Cross-references
Synonyms
- oxybutynin hydrochloride
- oxybutynin chloride
- oxytrol
- ditropan
- kentera
- oxybutynin HCl
- Oxybutynine
- Oxibutinina
- Contimin 2.5
- Contimin 5
- Cystrin
- Kentera
- Kentera (previously oxybutynin nicobrand)
- Lyrinel xl
- Oxytrol
- Oxytrol for women
- Promictuline
- Urimin
- Ditropan
- Oxibutyninum
- Oxybutyninum
- Oxybutyninum [INN-Latin]
- Oxybutynine [INN-French]
- Oxybutinin
- Oxibutinina [INN-Spanish]
- Oxybutynin Base
- transdermal patch
- Lyrinel XL
- Oxybutynin [USAN:INN:BAN]
- 4-Diethylamino-2-butinyl alpha-cyclohexylmandelat
- CCRIS 1923
- oxybutynin topical gel
- Ditropan Xl
- Oxybutynin (Ditropan)
- HSDB 3270
- 4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate
- CHEMBL1231
- Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-b
Reported adverse events
- Constipation
- Dizziness
- Dry mouth
- Urinary tract infection
- Dyspepsia
- Headache
- Insomnia
- Nausea
- Somnolence
- Nervousness
- Infection
- Amblyopia
Look up OXYBUTYNIN in the interactive SynDRA portal →